Detalles de la búsqueda
1.
Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir.
J Antimicrob Chemother
; 74(3): 710-717, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30541077
2.
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.
Eur J Clin Pharmacol
; 73(5): 593-600, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28233047
3.
Development of automated patch clamp assays to overcome the burden of variants of uncertain significance in inheritable arrhythmia syndromes.
Front Physiol
; 14: 1294741, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089476
4.
Multi-site validation of a functional assay to adjudicate SCN5A Brugada Syndrome-associated variants.
medRxiv
; 2023 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38196587
5.
A descriptive analysis of calls to the NSW Teratogen Information Service regarding use of anti-infectives during pregnancy.
PLoS One
; 17(10): e0270940, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36201464
6.
Design, synthesis, and evaluation of a novel dual FMS-like tyrosine kinase 3/stem cell factor receptor (FLT3/c-KIT) inhibitor for the treatment of acute myelogenous leukemia.
J Med Chem
; 54(20): 7184-92, 2011 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21970471
Resultados
1 -
6
de 6
1
Próxima >
>>